FDA Clearance Tracker · P960016
LIVEWIRE(R) CARDIAC ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: May 4, 1999 (this decision)Source: openFDAMethods & limitations
Decided
May 4, 1999
Approved
Time to decision
1,082 days
Received May 17, 1996. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P960016
- Device name
- LIVEWIRE(R) CARDIAC ABLATION SYSTEM
- Applicant
- St Jude Medical
- Applicant location
- Minnetonka, MN
- Received
- May 17, 1996
- Decided
- May 4, 1999
- Decision
- Approved
- Supplements
- 89 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Livewire TC(TM) Cardiac Ablation System. The device is indicated for cardiac electrophysiological mapping and for use with a compatible RF generator for: interruption of accessory atrioventricular (AV) conduction pathways assocated with tachycardia; the treatment of AV nodal re-entrant tachycardia (AVNRT); or creation of complete AV nodal block in patients with a difficult to control ventricular response to an atrial arrhythmia.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for St Jude Medical
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223077 · Decided Dec 7, 2022 · 68 days after receipt
Device type: Catheter, Ultrasound, Intravascular (OBJ) · Cardiology
P130026-S070 · Decided Nov 4, 2021 · 217 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
K212206 · Decided Aug 13, 2021 · 29 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (Without Arrhythmia Detection) (MXC) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.